CD200 and breast carcinoma: Investigation of the CD200–CD200R interaction in a murine breast cancer model revealed that deficiency of CD200R expression resulted in a reduction in tumor-infiltrating cytotoxic T cells and an increase in the release of inflammatory cytokines, including TNF-α and IL-6 [131].